Cervical cancer is emerging as the “fastest-rising form of cancer” in Canada, prompting health professionals to call for immediate action from the federal government to address what they describe as a “silent national health crisis.” This urgent message was conveyed at a press conference held by the Society of Gynecologic Oncology of Canada in Ottawa, highlighting the concerning statistics despite the government’s plan announced in July 2025 to eliminate cervical cancer as a public health issue by 2040.
The Alarming Statistics
Dr. Shannon Salvador, President of the Society of Gynecologic Oncology of Canada, emphasised the gravity of the situation, revealing that in 2025, approximately 1,650 Canadians would be diagnosed with cervical cancer, with around 430 expected to succumb to the disease—cases that she deemed largely preventable. “Canada is currently serving a silent national health crisis,” Dr. Salvador stated. “While many celebrate advancements in modern medicine, there exists an alarming outlier.”
The reliance on traditional Papanicolaou (Pap) tests has yielded diminishing returns, and the uptake of the human papillomavirus (HPV) vaccine has stagnated, with only 64 per cent of eligible individuals fully vaccinated—a figure significantly below the threshold necessary for effective disease elimination.
A Call for Change in Screening Practices
In response to these troubling trends, the Society of Gynecologic Oncology of Canada is advocating for a transformative approach to cervical cancer screening. They propose an immediate transition to HPV DNA testing and the implementation of self-collection kits. These measures aim to facilitate easier access to screening, particularly for those facing barriers related to geography, trauma history, or cultural marginalisation.
According to the Canadian Cancer Society, HPV testing can be conducted via a swab that collects cells from either the cervix or the vagina. Self-administered tests are available and enable individuals to gather samples privately, which could greatly enhance screening rates among underserved populations.
Addressing Health Disparities
Dr. Sarah Kean, provincial lead for cervical cancer in Manitoba, underscored the critical need for equitable access to screening resources. “Indigenous women, for example, are diagnosed at higher rates with more advanced stages of the disease, leading to poorer outcomes,” she explained. This disparity is not biological but stems from systemic issues such as geographic isolation, healthcare racism, and the lingering effects of colonialism.
Dr. Kean called for a “robust, accessible HPV screening across Canada” and urged federal legislators to support such initiatives. She stressed that this must go beyond mere updates to existing guidelines; it requires universal access to primary HPV testing across all provinces and territories, backed by clear national standards.
The Financial Burden of Inaction
The financial implications of cervical cancer are significant. Dr. Salvador noted that treating cervical cancer costs the Canadian healthcare system approximately $132 million annually, while screening eligible Canadians would amount to $106 million over a five-year period. The potential savings from preventing cases through improved screening and vaccination could alleviate some of this burden.
Despite the World Health Organization’s global strategy initiated five years ago to eliminate cervical cancer, recent reports suggest that Canada’s progress in this area has stalled. According to the Canadian Cancer Society, cervical cancer remains a leading cause of cancer-related deaths among women, with a five-year survival rate of 74 per cent and a ten-year survival rate of 68 per cent.
Why it Matters
The rising incidence of cervical cancer in Canada is not only a public health concern but also a poignant reminder of the systemic inequalities that persist within our healthcare framework. By prioritising accessible screening methods and comprehensive vaccination programmes, we can turn the tide against this preventable disease. The time for action is now—failure to address these issues could result in needless suffering and loss, particularly among the most vulnerable populations in our society. The health of our nation depends on it.
